Ravi Reddaboyna
About Ravi Reddaboyna
Ravi Reddaboyna is a Senior Manager of Statistical Programming at Kite Pharma, where he has worked since 2021. He has a background in statistical programming with previous roles at Gilead Sciences and holds a Master's degree in Chemistry from The University of Texas-Pan American.
Work at Kite Pharma
Ravi Reddaboyna currently serves as the Senior Manager of Statistical Programming at Kite Pharma, a role he has held since 2021. In this position, he oversees statistical programming activities and contributes to the development of innovative therapies. Prior to this, he worked as the Manager of Statistical Programming at Kite Pharma from 2019 to 2021, where he was involved in various projects that supported the company's mission in cell therapy.
Experience at Gilead Sciences
Ravi Reddaboyna worked at Gilead Sciences from 2013 to 2018, where he held several positions in statistical programming. He began as a Senior Statistical Programmer, contributing to data analysis and reporting. He then advanced to the role of Associate Manager of Statistical Programming from 2018 to 2019, where he managed programming teams and ensured the quality of statistical outputs.
Education and Expertise
Ravi Reddaboyna holds a Master of Science in Chemistry from The University of Texas-Pan American. He also earned a Bachelor's degree in Pharmacy from Osmania University. His educational background provides a strong foundation in both statistical methodologies and pharmaceutical sciences, enhancing his expertise in statistical programming within the biopharmaceutical industry.
Career Progression
Ravi Reddaboyna's career in statistical programming has shown a clear trajectory of growth and increasing responsibility. Starting at Gilead Sciences as a Senior Statistical Programmer, he progressed to Associate Manager before transitioning to Kite Pharma. His roles have involved significant contributions to statistical analysis and programming, demonstrating his capability in managing complex projects in the pharmaceutical sector.